JP2017014206A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017014206A5 JP2017014206A5 JP2016128584A JP2016128584A JP2017014206A5 JP 2017014206 A5 JP2017014206 A5 JP 2017014206A5 JP 2016128584 A JP2016128584 A JP 2016128584A JP 2016128584 A JP2016128584 A JP 2016128584A JP 2017014206 A5 JP2017014206 A5 JP 2017014206A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- day
- patient
- months
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562186638P | 2015-06-30 | 2015-06-30 | |
| US62/186,638 | 2015-06-30 | ||
| US201562267510P | 2015-12-15 | 2015-12-15 | |
| US62/267,510 | 2015-12-15 | ||
| US201662321558P | 2016-04-12 | 2016-04-12 | |
| US62/321,558 | 2016-04-12 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018145654A Division JP2018172440A (ja) | 2015-06-30 | 2018-08-02 | 腹水の治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017014206A JP2017014206A (ja) | 2017-01-19 |
| JP2017014206A5 true JP2017014206A5 (en:Method) | 2017-08-31 |
Family
ID=57609113
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016128584A Pending JP2017014206A (ja) | 2015-06-30 | 2016-06-29 | 腹水の治療 |
| JP2018145654A Pending JP2018172440A (ja) | 2015-06-30 | 2018-08-02 | 腹水の治療 |
| JP2020115254A Pending JP2020172520A (ja) | 2015-06-30 | 2020-07-03 | 腹水の治療 |
| JP2022107055A Pending JP2022136104A (ja) | 2015-06-30 | 2022-07-01 | 腹水の治療 |
| JP2023133333A Pending JP2023160839A (ja) | 2015-06-30 | 2023-08-18 | 腹水の治療 |
| JP2025107051A Pending JP2025143324A (ja) | 2015-06-30 | 2025-06-25 | 腹水の治療 |
Family Applications After (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018145654A Pending JP2018172440A (ja) | 2015-06-30 | 2018-08-02 | 腹水の治療 |
| JP2020115254A Pending JP2020172520A (ja) | 2015-06-30 | 2020-07-03 | 腹水の治療 |
| JP2022107055A Pending JP2022136104A (ja) | 2015-06-30 | 2022-07-01 | 腹水の治療 |
| JP2023133333A Pending JP2023160839A (ja) | 2015-06-30 | 2023-08-18 | 腹水の治療 |
| JP2025107051A Pending JP2025143324A (ja) | 2015-06-30 | 2025-06-25 | 腹水の治療 |
Country Status (7)
| Country | Link |
|---|---|
| US (6) | US9655945B2 (en:Method) |
| EP (2) | EP3347032B1 (en:Method) |
| JP (6) | JP2017014206A (en:Method) |
| CN (2) | CN120324576A (en:Method) |
| ES (1) | ES2971959T3 (en:Method) |
| HK (1) | HK1258611A1 (en:Method) |
| WO (1) | WO2017004317A1 (en:Method) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0918652B1 (pt) | 2008-09-17 | 2021-10-19 | Chiasma, Inc. | Composição farmacêutica compreendendo um meio hidrofóbico e uma forma sólida que compreende polipeptídeo e sal de ácido graxo de cadeia média, processo de produção da mesma e forma de dosagem oral |
| DK3978074T3 (da) | 2014-10-24 | 2024-05-13 | Mallinckrodt Pharmaceuticals Ireland Ltd | Terlipressin til behandling af hepatorenalt syndrom type 1 |
| HUE071943T2 (hu) | 2015-02-03 | 2025-10-28 | Amryt Endo Inc | Akromegália kezelése oktreotid orális alkalmazásával |
| JP2017014206A (ja) * | 2015-06-30 | 2017-01-19 | ナノアンティバイオティクス，インコーポレイテッド | 腹水の治療 |
| EP3528828B1 (en) | 2016-10-21 | 2025-01-29 | Amryt Endo, Inc. | Terlipressin composition for use in treating ascites |
| CN112704727B (zh) * | 2021-01-12 | 2023-05-16 | 重庆医科大学附属第二医院 | 特利加压素在制备动力性肠梗阻药物中的应用 |
| CN113077888A (zh) * | 2021-03-30 | 2021-07-06 | 福州宜星大数据产业投资有限公司 | 自动化meld评分方法、终端及存储介质 |
| WO2023150254A1 (en) * | 2022-02-03 | 2023-08-10 | Biovie Inc. | Methods of treating disease with terlipressin |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1188443A1 (en) * | 2000-09-15 | 2002-03-20 | Ferring BV | Improved protocol for paracentesis |
| PL1984012T3 (pl) * | 2006-02-13 | 2016-07-29 | Ferring Bv | Zastosowanie peptydowych agonistów receptora wazopresyny |
| WO2009037586A2 (en) * | 2007-08-14 | 2009-03-26 | Ferring B.V. | Use of peptidic vasopressin receptor agonists |
| EP2203172A2 (en) * | 2007-09-28 | 2010-07-07 | Ferring B.V. | Use of v2 receptor antagonists in combination with vasopressinergic agonists |
| EP2214709A4 (en) * | 2007-11-08 | 2011-05-11 | Univ Utah Res Found | USE OF ANGIOGENESIS ANTAGONISTS IN DISEASES WITH ANOMAL VENEER PREPARATION |
| US8815232B2 (en) | 2008-08-26 | 2014-08-26 | Kyon Biotech Ag | Compositions and methods for treating cancer |
| EP2406399B1 (en) * | 2009-03-09 | 2018-02-14 | Bioatla, LLC | Mirac proteins |
| MX375116B (es) * | 2009-06-08 | 2025-03-06 | Ucl Business Plc | Tratamiento de hipertension portal y restauracion de la funcion hepatica usando fenilacetato de l-ornitina. |
| EP2593541A4 (en) * | 2010-07-14 | 2014-01-22 | Cumberland Emerging Technologies Inc | METHOD FOR THE TREATMENT OF HEPATORENAL SYNDROME AND HEPATIC ENZEPHALOPATHY WITH THROMBOXANE A2 RECEPTOR ANTAGONISTS |
| WO2013106072A1 (en) | 2012-01-10 | 2013-07-18 | Sorbent Therapeutics, Inc. | Compositions comprising crosslinked cation-binding polymers and uses thereof |
| JO3109B1 (ar) | 2012-05-10 | 2017-09-20 | Ferring Bv | منبهات لمستقبلات v1a |
| CN102731625B (zh) * | 2012-06-27 | 2014-10-15 | 深圳翰宇药业股份有限公司 | 一种纯化特利加压素的方法 |
| WO2014075082A1 (en) | 2012-11-12 | 2014-05-15 | Gregory Thomas Everson | Disease severity index for assessment of chronic liver disease and method for diagnosis of three distinct subtypes of primary sclerosing cholangitis |
| CN105592855A (zh) * | 2013-04-26 | 2016-05-18 | 拉卓拉药物公司 | 用于治疗肾衰竭的组合物和方法 |
| CN104510840A (zh) | 2013-08-21 | 2015-04-15 | 乔治亚摄政研究学院有限公司 | 改性绿茶多酚和其用于治疗肝病的方法 |
| JP2017014206A (ja) * | 2015-06-30 | 2017-01-19 | ナノアンティバイオティクス，インコーポレイテッド | 腹水の治療 |
-
2016
- 2016-06-29 JP JP2016128584A patent/JP2017014206A/ja active Pending
- 2016-06-30 EP EP16818751.6A patent/EP3347032B1/en active Active
- 2016-06-30 CN CN202510468211.6A patent/CN120324576A/zh active Pending
- 2016-06-30 ES ES16818751T patent/ES2971959T3/es active Active
- 2016-06-30 US US15/198,050 patent/US9655945B2/en not_active Expired - Fee Related
- 2016-06-30 HK HK19100970.3A patent/HK1258611A1/zh unknown
- 2016-06-30 CN CN201680003239.1A patent/CN106999539A/zh active Pending
- 2016-06-30 WO PCT/US2016/040284 patent/WO2017004317A1/en not_active Ceased
- 2016-06-30 EP EP23212473.5A patent/EP4338795A3/en active Pending
-
2017
- 2017-04-19 US US15/491,613 patent/US20180000887A1/en not_active Abandoned
-
2018
- 2018-08-02 JP JP2018145654A patent/JP2018172440A/ja active Pending
-
2019
- 2019-04-09 US US16/379,446 patent/US11364277B2/en active Active
-
2020
- 2020-07-03 JP JP2020115254A patent/JP2020172520A/ja active Pending
-
2022
- 2022-06-03 US US17/831,556 patent/US20230146264A1/en not_active Abandoned
- 2022-07-01 JP JP2022107055A patent/JP2022136104A/ja active Pending
-
2023
- 2023-08-18 JP JP2023133333A patent/JP2023160839A/ja active Pending
-
2024
- 2024-01-23 US US18/420,332 patent/US20240165193A1/en not_active Abandoned
-
2025
- 2025-06-12 US US19/236,445 patent/US20250312410A1/en active Pending
- 2025-06-25 JP JP2025107051A patent/JP2025143324A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017014206A5 (en:Method) | ||
| JP2018172440A5 (en:Method) | ||
| JP2018193377A5 (en:Method) | ||
| JP2015083580A5 (en:Method) | ||
| JP2013525444A5 (en:Method) | ||
| JP2012193216A5 (en:Method) | ||
| JP2013509429A5 (en:Method) | ||
| EA201401028A1 (ru) | Фармацевтическая композиция, содержащая эмпаглифлозин и лекарственное средство от ожирения | |
| JP2016515561A5 (en:Method) | ||
| JP2012512907A5 (en:Method) | ||
| IL292465B2 (en) | Neuroactive compounds and methods of use thereof | |
| CN111836807A (zh) | 氧杂螺环类化合物及其制备方法和用途 | |
| JP2020097577A5 (en:Method) | ||
| JP2017500289A5 (en:Method) | ||
| JP2015516419A5 (en:Method) | ||
| RU2015134581A (ru) | Доноры нитроксила с улучшенным терапевтическим индексом | |
| JP2013166781A5 (en:Method) | ||
| JP2016510326A5 (en:Method) | ||
| JP2013541583A5 (en:Method) | ||
| JP2019529541A5 (en:Method) | ||
| JP2017508817A5 (en:Method) | ||
| JP2018509419A5 (en:Method) | ||
| JP2018503644A5 (en:Method) | ||
| JP2015522603A5 (en:Method) | ||
| JP2019518022A5 (en:Method) |